ResMed Inc.

NYSE: RMD · Real-Time Price · USD
284.69
-3.59 (-1.25%)
At close: Aug 14, 2025, 3:59 PM
284.72
0.01%
Pre-market: Aug 15, 2025, 07:10 AM EDT

ResMed Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
5.15B 4.69B 4.22B 3.58B 3.2B
Cost of Revenue
2.09B 2.03B 1.87B 1.55B 1.36B
Gross Profit
3.05B 2.66B 2.36B 2.02B 1.84B
Operating Income
1.69B 1.32B 1.13B 1B 903.68M
Interest Income
4.11M n/a n/a n/a 362K
Pretax Income
1.68B 1.26B 1.1B 960.48M 883.66M
Net Income
1.4B 1.02B 897.56M 779.44M 474.5M
Selling & General & Admin
991.02M 917.14M 874M 739.37M 670.39M
Research & Development
331.28M 307.52M 287.64M 253.57M 225.28M
Other Expenses
47.3M 110.75M 62.15M 31.08M 39.75M
Operating Expenses
1.37B 1.34B 1.22B 1.02B 935.42M
Interest Expense
n/a 45.71M 47.38M 22.31M 23.99M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
3.46B 3.37B 3.09B 2.58B 2.29B
Income Tax Expense
276.84M 243.85M 204.11M 181.05M 409.16M
Shares Outstanding (Basic)
146.72M 147.02M 146.76M 146.07M 145.31M
Shares Outstanding (Diluted)
147.34M 147.55M 147.46M 147.04M 146.45M
EPS (Basic)
9.55 6.94 6.12 5.34 3.27
EPS (Diluted)
9.51 6.92 6.09 5.30 3.24
EBITDA
1.91B 1.53B 1.36B 1.18B 1.1B
EBIT
1.68B 1.31B 1.16B 982.79M 912.35M
Depreciation & Amortization
235.81M 216.21M 196.52M 193.84M 191.52M